A detailed history of Gamma Investing LLC transactions in Sc Pharmaceuticals Inc. stock. As of the latest transaction made, Gamma Investing LLC holds 265 shares of SCPH stock, worth $916. This represents 0.0% of its overall portfolio holdings.

Number of Shares
265
Previous 101 162.38%
Holding current value
$916
Previous $439,000 175.17%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 04, 2024

BUY
$4.12 - $5.51 $675 - $903
164 Added 162.38%
265 $1.21 Million
Q2 2024

Jul 02, 2024

SELL
$3.51 - $5.21 $2,569 - $3,813
-732 Reduced 87.88%
101 $439,000
Q1 2024

Apr 05, 2024

BUY
$4.86 - $6.39 $102 - $134
21 Added 2.59%
833 $4.18 Million
Q4 2023

Feb 01, 2024

BUY
$4.7 - $6.63 $3,816 - $5,383
812 New
812 $3.98 Million

Others Institutions Holding SCPH

About scPharmaceuticals Inc.


  • Ticker SCPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 27,402,100
  • Market Cap $94.8M
  • Description
  • scPharmaceuticals Inc., a pharmaceutical company, engages in the development and commercialization of various pharmaceutical products. The company's lead product candidate is FUROSCIX that consists of formulation of furosemide, which is delivered through an on-body infusor for treatment of congestion in patients with heart failure. Its product p...
More about SCPH
Track This Portfolio

Track Gamma Investing LLC Portfolio

Follow Gamma Investing LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gamma Investing LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gamma Investing LLC with notifications on news.